Over 1150 Total Lots Up For Auction at Three Locations - WI 07/09, NJ Cleansweep 07/10, CA 07/11

Joseph J. Cappello

Are You Dense, Inc. and Are You Dense Advocacy, Inc. announce executive director of both organizations
February 19, 2019
Women's Health
Joseph J. Cappello
Woodbury, Conn., Feb. 18, 20019 — The boards of the two nonprofits founded by the late Nancy M. Cappello, PhD, has announced today Joseph J. Cappello as their new executive director. For over a decade, Mr. Cappello has worked tirelessly, side-by-side as co-founder of the organizations with his wife, Dr. Cappello, earning him a unique perspective of the critical issue on adjunct screening for women with dense breast tissue.

"Duty compels me to carry on my wife's mission," declares Mr. Cappello. "Women have the right to know their breast density status, to have their complete breast health information. This vital piece of information was denied to Nancy when she was originally diagnosed with late stage 3c breast cancer in 2004. As a result of her hard work, 36 states currently mandate physicians to tell their patients their breast density status.

"Now, we are focusing our energies on getting legislation passed in the remaining 14 states" adds Mr. Cappello.
stats
DOTmed text ad

Ensure critical devices are ready to go

Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.

stats Advertisement
Science for decades has demonstrated that dense breast tissue is associated with a higher-than-average risk of breast cancer and that dense breast tissue can mask cancers on mammograms, making them impossible to detect. Adjunct screening to mammography, such as ultrasound and MRI, significantly increase detection of early cancers in dense breasts.

Dr. Cappello launched the legislative action of her organizations after being diagnosed with advanced-stage breast cancer in 2004 despite decades of normal mammography results. None of Dr. Cappello's physicians told her that she had dense breast tissue, which had hidden the growing cancer in her breast, and none advised her to get adjunct screening. Her home state of Connecticut passed the first bill in 2009.

Dr. Cappello passed away this past November due to complications from Myelodysplastic syndrome (MDS), a rare form of bone marrow cancer, and in some instances, may be associated with previous radiation and chemotherapy cancer treatments.

"I am empowered and honored to further the Are You Dense? mission," continues Mr. Cappello. "That being to reduce missed, delayed and advanced stage breast cancer by increasing access to early detection for women with dense breasts leading to reduced harms from aggressive treatments and better survival outcomes."

You Must Be Logged In To Post A Comment

 

spacer

Women's Health Homepage

Geisinger rolls out 3D mammography across all sites
Offers improved visibility of dense tissue compared to traditional 2D mammograms
FDA clears AI platform for mammogram-based five-year breast cancer risk prediction
Allix5 was trained on millions of mammographic images and validated across more than 77,000 scans
Abbreviated breast MR matches accuracy of full scans in dense breast cancer screening
Some of the MR scans took less than five minutes to complete
Stanford Medicine first to use fluorescent dye to cut repeat breast surgeries
LumiSystem illuminates cancer cells that may remain after tumor removal
Multidisciplinary breast cancer care cuts treatment delays at safety net hospital, study finds
Began treatment on average 35 days after diagnosis, compared to 49.6 days for those in standard care
iCAD integrates mammo AI into Microsoft’s Precision Imaging Network
Bringing the ProFound Breast Health Suite to PowerScribe platform
SimonMed taps Lunit AI to enhance breast cancer detection services
Will incorporate Lunit software alongside Volpara Analytics to power its Personalized Breast Cancer Detection program
RadNet to acquire iCAD in $103 million all-stock deal focused on breast cancer AI
Will integrate software into DeepHealth
Amirix Imaging secures exclusive North American rights to Kailong mammo X-ray tubes
The LM33-T tube is marketed as a direct replacement for the Varex M113-T used in Hologic’s Dimensions and 3Dimensions systems
AI tool flags cardiovascular risk using mammograms, study shows
Assesses breast arterial calcification — calcium deposits visible on mammogram